[1]
“THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION.: Clinical Evaluation of T-AML ”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023051, Aug. 2023, doi: 10.4084/MJHID.2023.051.